Prof. Herbert Kwok obtained his MBBS degree from the University of Hong Kong. He completed his specialty training in Respiratory Medicine and Advanced Internal Medicine at the Queen Mary Hospital. He joined the Department of Medicine, the University of Hong Kong, as a Clinical Assistant Professor subsequently.  
 
Prof. Kwok’s research interests include airway diseases including asthma, bronchiectasis and chronic obstructive pulmonary diseases. Lung cancer is another area that Prof. Kwok is actively working on. He was awarded the Li Shu Fan Fellowship for Internal Medicine to support his study in phenotyping and therapeutics of airway diseases. He was also awarded competitive research grant to support his research in respiratory medicine, namely Health and Medical Research Fund, Pneumoconiosis Compensation Fund Board (PCFB) Research Fund, Hong Kong Lung Foundation Research Grant, Hong Kong College of Physicians Young Investigator Research Grant, Hong Kong Obesity Society Research Fund and The Hong Kong Institute of Allergy Research Grant. 
 
Prof. Kwok was awarded the Asian Pacific Society of Respirology (APSR 2024): Hong Kong Lung Foundation Professor Wah-kit Lam Young Investigator Award, Travel grant to 2024 Korean Academy of Tuberculosis and Respiratory Diseases International Conference (KATRDIC 2024, Outstanding Author of the Journal of Thoracic Disease 2024, APSR Travel Award to the JRS Annual Meeting 2024, Assembly Education Award [Respiratory Structure and Function Assembly] and [Respiratory Infections (non-tuberculous) Assembly] in the 26th Congress of the Asia Pacific Society of Respirology 2022, best oral presentation in the 8th Asia Pacific Region Conference of International Union Against Tuberculosis and Lung Disease (2022), Asian Pacific Society of Respirology Teaching Library Award (2019), best Abstract of the Assembly (Clinical Respiratory Medicine) in the 22nd Congress of the Asia Pacific Society of Respirology (2017) and Professor Wah-kit Lam Young Investigator Award 2017/2018 in recognition of his research work.

1. Vice-president, Hong Kong Public Doctor Association
2. Council member, Hong Kong Medical Association
3. Editor, Hong Kong Medical Journal
4. Academic Editor, Case Reports in Medicine 
5. Advisory board member of Advances in Therapy 
6. Editorial Board Member of Discover Respiratory Physiology 
7. Young Fellow, Scientific Committee, Hong Kong College of Physicians
8. Honorary Advisor for Paediatric Home Respiratory Support Society
9. Committee Member,  Scientic Committee And Newsletter and Website committee, Hong Kong Thoracic Society, CHEST Delegation Hong Kong & Macau, Hong Kong Lung Foundation 
   

1. Travel grant to 2024 Korean Academy of Tuberculosis and Respiratory Diseases International Conference (KATRDIC 2024) 
2. APSR-Hong Kong Lung Foundation Professor Wah-kit Lam Young Investigator Award 2024 
3. Outstanding Author of the Journal of Thoracic Disease 2024
4. APSR Travel Award to the JRS Annual Meeting 2024
5. Assembly Education Award [Respiratory Structure and Function Assembly] 26th Congress of the Asia Pacific Society of Respirology 2022
6. Assembly Education Award [Respiratory Infections (non-tuberculous) Assembly] 26th Congress of the Asia Pacific Society of Respirology 2022
7. Best Oral presentation, 8th Asia Pacific Region Conference of International Union Against Tuberculosis and Lung Disease (APRC 2022)
8. Li Shu Fan Medical Scholarship for Internal Medicine 2020/21
9. Asian Pacific Society of Respirology Teaching Library Award 2019
10. Best Abstract of the Assembly (Clinical Respiratory Medicine) – 22nd Congress of the Asia Pacific Society of Respirology 2017
11. Professor Wah-kit Lam Young Investigator Award Merit 2017-2018

1. Impact of hyponatraemia at clinical stable-state on survival in patients with chronic obstructive pulmonary disease, International Journal of Chronic Obstructive Pulmonary Disease (In press) 
2. Prospective randomized study on switching triple inhaler therapy in COPD from multiple inhaler devices to single inhaler device in Chinese population, Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (In press) 
3. Bronchiectasis exacerbation increases the risk of adverse renal outcomes – Results from a large territory-wide cohort study, The Clinical Respiratory Journal (In press) 
4. Kwok WC, Lau KK, Teo KC, Ho JCM. Correlation of sputum inflammatory markers with severity and blood inflammatory markers in bronchiectasis. J Thorac Dis. Aug 31 2024;16(8):5190-5200. doi:10.21037/jtd-24-573 
5. Kwok WC, Yap DYH, Tam TCC, Lam DCL, Ip MSM, Ho JCM. Impact of hyponatraemia during exacerbation on clinical outcomes in patients with bronchiectasis. Int J Tuberc Lung Dis. 2024;28(11):534-40.
6. Kwok WC, Tam TCC, Ho JCM, Lam DCL, Ip MSM, Yap DYH. The impact of bronchiectasis and its severity on long-term renal outcomes. Int J Tuberc Lung Dis. 2024;28(9):427-32. 
7. Kwok WC, Lung DC, Tam TC, Yap DY, Ma TF, Tsui CK, et al. Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza-A Territory-Wide Study. Vaccines (Basel). 2024;12(7). 
8. Kwok WC, Chau CH, Tam TCC, Lam FM, Ho JCM. Outcomes among patients with chronic obstructive pulmonary disease after recovery from COVID-19 infection of different severity. Sci Rep. 2024;14(1):13881. 
9. Kwok WC, Ho JCM, Lam DCL, Ip MSM, Tam TCC. Baseline neutrophil-to-lymphocyte ratio as a predictor of response to hospitalized bronchiectasis exacerbation risks. Eur Clin Respir J. 2024;11(1):2372901. 
10. Kwok WC, Tam TCC, Lam DCL, Ip MSM, Ho JCM. Systemic immune-inflammation index in predicting hospitalized bronchiectasis exacerbation risks and disease severity. J Thorac Dis. May 31 2024;16(5):2767-2775. doi:10.21037/jtd-23-1392 
11. Kwok WC, Tsui CK, Leung SHI, et al. Cardiovascular outcomes following hospitalisation for exacerbation of bronchiectasis: a territory-wide study. BMJ Open Respir Res 2024;11(1) doi: 10.1136/bmjresp-2023-001804 [published Online First: 20240418] 
12. Kwok WC, Teo KC, Lau KK, Ho JC. High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk. BMC Pulm Med. 2024;24(1):80. 
13. Kwok WC, Tam TCC, Ho JCM, Lam DCL, Ip MS, Ho PL. Real-World Effectiveness Study of Nirmatrelvir-Ritonavir or Molnupiravir in Hospitalized Unvaccinated Patients with Chronic Respiratory Diseases and Moderate COVID-19 at Presentation. Int J Chron Obstruct Pulmon Dis. 2024;19:77-86. 
14. Kwok WC, Ho JCM, Tam TCC, Ip MSM, Lam DCL. Increased exacerbations of bronchiectasis following recovery from mild COVID-19 in patients with non-cystic fibrosis bronchiectasis. Respirology. 2024. 
15. Kwok WC, Tam TCC, Ho JCM, Lam DCL, Ip MSM, Yap DYH. Hospitalized acute exacerbation in chronic obstructive pulmonary disease - impact on long-term renal outcomes. Respir Res. 2024;25(1):36. 
16. Kwok WC, Ma TF, Ho JCM, Lam DCL, Sit KY, Ip MSM, et al. Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma. Respirology. 2023. 
17. Kwok WC, Chau CH, Tam TCC, Lam FM, Ho JCM. Variability of Blood Eosinophil Count at Stable-State in Predicting Exacerbation Risk of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2023;18:1145-53. 
18. Kwok WC, Ho JCM, Ma TF, Lam DCL, Chan JWM, Ip M, et al. Risk of hospitalised bronchiectasis exacerbation based on blood eosinophil counts. Int J Tuberc Lung Dis. 2023;27(1):61-5. 
19. Kwok WC, Tsoi MF, Leung SHI, Tsui CK, Tam TCC, Ho JCM, et al. Real-World Study on Effectiveness of Molnupiravir and Nirmatrelvir–Ritonavir in Unvaccinated Patients with Chronic Respiratory Diseases with Confirmed SARS-CoV-2 Infection Managed in Out-Patient Setting. Viruses [Internet] 2023;15(3):610. 
20. Kwok WC, Tam TCC, Lam DCL, Leung JKC, Chan KPF, Chan SKS, et al. Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong. Respir Res. 2023;24(1):53. 
21. Kwok WC, Leung SHI, Tam TCC, Ho JCM, Lam DC, Ip MSM, et al. Efficacy of mRNA and Inactivated Whole Virus Vaccines Against COVID-19 in Patients with Chronic Respiratory Diseases. Int J Chron Obstruct Pulmon Dis. 2023;18:47-56. 
22. Kwok WC,Cheung KS, Ho JCM, Li B, Ma TF, Leung WK. High-dose proton pump inhibitors are associated with hospitalisation in bronchiectasis exacerbation. Int J Tuberc Lung Dis. 2022;26(10):917-21. 
23. Kwok WC,Tam AR, Ho JCM, Lam DCL, Tam TCC, Chan KPF, et al. Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19). Clin Respir J. 2022 
24. Kwok WC, Chiang KY, Ho JCM, Lam DCL, Ip MSM, Tam TCC. Risk factors of nephrotoxicity of maintenance pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung. Lung Cancer. 2021;162:169-74. 
25. Kwok WC, HoJCM, Tam TCC, Ip MSM, Lam DCL. Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications. Respir Res. 2021;22(1):132.  
26. Kwok WC,Cheong TF, Chiang KY, Ho JCM, Lam DCL, Ip MSM, Tam TCC. Haematological toxicity of pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung with third-space fluid. Lung Cancer. 2020;152:15-20. 
27. Kwok WC, Liang BM, Lui MMS, Tam TCC, Sim JPY, Tse EWC, Leung AYH, Kwong YL, Lie AKW, Ip MSM, Lam DCL. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome. Respirology. 2019;24(5):459-66.